We reposting an article of Monday about post-marketing surveillance for biosimilars.

#Biosimilars #Pharmacovigilance #ClinicalResearch #RealWorldEvidence #CDSCO #Pharma #CRO #ClinicalTrials

https://genelifecr.blogspot.com/2026/05/post-marketing-surveillance-for.html

Biosimilar approval is not the finish line.
It's the point at which your pre-approval dataset — intentionally smaller than a novel biologic — meets real patients, real clinical practice, and real immune systems.

PMS isn't overhead. It's the second half of your evidence strategy.

#Biosimilars #Pharmacovigilance #ClinicalResearch #Pharma #CRO #CDSCO #ClinicalTrials #genelife

https://genelifecr.blogspot.com/2026/05/post-marketing-surveillance-for.html

Your website may be getting traffic, but if visitors are not turning into leads, there is a conversion problem. This article explains why traffic alone is not enough and how to fix the gaps in your website funnel.

https://www.outsourcing-eg.com/website-traffic-no-conversions/

#ConversionOptimization #LeadGeneration #CRO #WebsiteOptimization #DigitalMarketing #5DOutsourcing

https://www.outsourcing-eg.com/website-traffic-no-conversions/

Chtěl jsem jít na dnešní demošku za #ČRo a #ČT, ale právě jsem se vrátil ze šichty na zahradě.

Mám takový pocit, že když tam bude o jedno tělo míň, taky se svět nezhroutí.